As of Feb 22
| 0.00 / 0.00%|
The 11 analysts offering 12-month price forecasts for Insmed Inc have a median target of 35.00, with a high estimate of 56.00 and a low estimate of 22.00. The median estimate represents a +22.85% increase from the last price of 28.49.
The current consensus among 10 polled investment analysts is to Buy stock in Insmed Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.